• 1
    Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network—Transplant Data: 1991-2000. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, 2000. Available at: Accessed: September 10, 2002.
  • 2
    Otero J, Rodriguez M, Escudero D, Gomez E, Aguado S, de Ona M. Kidney transplants with positive anti-hepatitis C virus donors. Transplantation 1990; 50:10861087.
  • 3
    Pereira B, Milford E, Kirkman R, Levey A. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325:454460.
  • 4
    Pereira B, Milford E, Kirkman R, Quan S, Sayre K, Johnson P, et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 327:910915.
  • 5
    Wreghitt TG, Gray JJ, Allain JP, Poulain J, Garson JA, Deaville R, et al. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 1994; 20:768772.
  • 6
    Pereira BJ, Wright TL, Schmid CH, Levey AS. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group. Lancet 1995; 345:484487.
  • 7
    Everhart JE, Wei Y, Eng H, Charlton MR, Persing DH, Wiesner RH, et al. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 1999; 29:12201226.
  • 8
    Pereira BJ, Wright TL, Schmid CH, Bryan CF, Cheung RC, Cooper ES, et al. Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: A US National Collaborative Study. Kidney Int 1994; 46:886892.
  • 9
    Mulligan DC, Goldstein RM, Crippin JS, Abouljoud MS, Levy MF, Husberg BS, et al. Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplant Proc 1995; 27:12041205.
  • 10
    Aswad S, Mendez R, Weingart RG. Expanding organ availability by using hepatitis C antibody positive donors. Transplant Proc 1993; 25:22702271.
  • 11
    Feray C, Shouval D, Samuel D. Will transplantation of a hepatitis C-infected graft improve the outcome of liver transplantation in HCV patients? Gastroenterology 1999; 117:263265.
  • 12
    Torres M, Weppler D, Reddy KR, Tzakis A. Use of hepatitis C-infected donors for hepatitis C-positive OLT recipients. Gastroenterology 1999; 117:1253.
  • 13
    Testa G, Goldstein RM, Netto G, Abbasoglu O, Brooks BK, Levy MF, et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation 1998; 65:925929.
  • 14
    Vargas HE, Laskus T, Wang LF, Lee R, Radkowski M, Dodson F, et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999; 117:149153.
  • 15
    Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, et al. A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients. Ann Surg 2001; 234: 384393; discussion, 393–384.
  • 16
    Velidedeoglu E, Desai NM, Campos L, Olthoff KM, Shaked A, Nunes F, et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002; 73(4):582587.
  • 17
    Marroquin CE, Marino G, Kuo PC, Plotkin JS, Rustgi VK, Lu AD, et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl 2001; 7:762768.
  • 18
    Laskus T, Wang LF, Rakela J, Vargas H, Pinna AD, Tsamandas AC, et al. Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology 1996; 220:171176.
  • 19
    Radkowski M, Wang LF, Vargas H, Wilkinson J, Rakela J, Laskus T. Changes in hepatitis C virus population in serum and peripheral blood mononuclear cells in chronically infected patients receiving liver graft from infected donors. Transplantation 2001; 72:833838.